Maternal and foetal placental vascular malperfusion in pregnancies with anti-phospholipid antibodies. 2021

Arsenio Spinillo, and Camilla Bellingeri, and Chiara Cavagnoli, and Irene De Maggio, and Greta Riceputi, and Beatrice Ruspini, and Stefania Cesari, and Fausta Beneventi
Department of Obstetrics and Gynecology, IRCCS Policlinico San Matteo, Pavia, Italy.

The objective of the study was to evaluate the rates of pathological placental lesions among pregnant subjects positive for aPL antibodies. We performed a longitudinal case-control study including 27 subjects with primary APS, 51 with non-criteria APS, 24 with aPL antibodies associated with other well-known CTDs enrolled at the end of the first trimester of pregnancy and 107 healthy controls. Compared with controls and after correction for multiple comparisons, primary, non-criteria APS and aPL associated to CTD, subjects had lower placental weight, volume and area. After penalized logistic regression analysis to correct for potential confounders, placental lesions suggesting severe maternal vascular malperfusion (MVM) were more common among primary [odds ratio (OR) 11.7 (95% CI 1.3, 108)] and non-criteria APS [OR 8.5 (95% CI 1.6, 45.9)] compared with controls. The risk of foetal vascular malperfusion (FVM) was higher in primary APS [OR 4.5 (95% CI 1.2, 16.4)], aPL associated with CTDs [OR 3.1 (95% CI 1.5, 6.7)] and non-criteria APS [OR 5.9 (95% CI 1.7, 20.1)] compared with controls. Among clinical and laboratory criteria of APS, first trimester aCL IgG >40 UI/ml [OR 4.4 (95% CI 1.3, 14.4)], LA positivity [OR 6.5 (95% CI 1.3, 33.3)] and a history of pre-eclampsia at <34 weeks [OR 32.4 (95% CI 6.5, 161)] were the best independent first trimester predictors of severe MVM [area under the curve 0.74 (95% CI 0.6, 0.87)]. Compared with healthy controls, pregnant subjects with aPL antibodies have an increased risk of placental lesions, suggesting MVM and FVM. First-trimester variables such as aCL IgG >40 UI/ml and a history of pre-eclampsia were significant predictors of both severe MVM and FVM.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D008137 Longitudinal Studies Studies in which variables relating to an individual or group of individuals are assessed over a period of time. Bogalusa Heart Study,California Teachers Study,Framingham Heart Study,Jackson Heart Study,Longitudinal Survey,Tuskegee Syphilis Study,Bogalusa Heart Studies,California Teachers Studies,Framingham Heart Studies,Heart Studies, Bogalusa,Heart Studies, Framingham,Heart Studies, Jackson,Heart Study, Bogalusa,Heart Study, Framingham,Heart Study, Jackson,Jackson Heart Studies,Longitudinal Study,Longitudinal Surveys,Studies, Bogalusa Heart,Studies, California Teachers,Studies, Jackson Heart,Studies, Longitudinal,Study, Bogalusa Heart,Study, California Teachers,Study, Longitudinal,Survey, Longitudinal,Surveys, Longitudinal,Syphilis Studies, Tuskegee,Syphilis Study, Tuskegee,Teachers Studies, California,Teachers Study, California,Tuskegee Syphilis Studies
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D010920 Placenta A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES). Placentoma, Normal,Placentome,Placentas,Placentomes
D010927 Placental Insufficiency Failure of the PLACENTA to deliver an adequate supply of nutrients and OXYGEN to the FETUS. Insufficiency, Placental
D011225 Pre-Eclampsia A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease. Toxemias, Pregnancy,EPH Complex,EPH Gestosis,EPH Toxemias,Edema-Proteinuria-Hypertension Gestosis,Gestosis, EPH,Hypertension-Edema-Proteinuria Gestosis,Preeclampsia,Preeclampsia Eclampsia 1,Pregnancy Toxemias,Proteinuria-Edema-Hypertension Gestosis,Toxemia Of Pregnancy,1, Preeclampsia Eclampsia,1s, Preeclampsia Eclampsia,EPH Toxemia,Eclampsia 1, Preeclampsia,Eclampsia 1s, Preeclampsia,Edema Proteinuria Hypertension Gestosis,Gestosis, Edema-Proteinuria-Hypertension,Gestosis, Hypertension-Edema-Proteinuria,Gestosis, Proteinuria-Edema-Hypertension,Hypertension Edema Proteinuria Gestosis,Of Pregnancies, Toxemia,Of Pregnancy, Toxemia,Pre Eclampsia,Preeclampsia Eclampsia 1s,Pregnancies, Toxemia Of,Pregnancy Toxemia,Pregnancy, Toxemia Of,Proteinuria Edema Hypertension Gestosis,Toxemia Of Pregnancies,Toxemia, EPH,Toxemia, Pregnancy,Toxemias, EPH
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011248 Pregnancy Complications Conditions or pathological processes associated with pregnancy. They can occur during or after pregnancy, and range from minor discomforts to serious diseases that require medical interventions. They include diseases in pregnant females, and pregnancies in females with diseases. Adverse Birth Outcomes,Complications, Pregnancy,Adverse Birth Outcome,Birth Outcome, Adverse,Complication, Pregnancy,Outcome, Adverse Birth,Pregnancy Complication
D011261 Pregnancy Trimester, First The beginning third of a human PREGNANCY, from the first day of the last normal menstrual period (MENSTRUATION) through the completion of 14 weeks (98 days) of gestation. Early Placental Phase,Pregnancy, First Trimester,Trimester, First,Early Placental Phases,First Pregnancy Trimester,First Pregnancy Trimesters,First Trimester,First Trimester Pregnancies,First Trimester Pregnancy,First Trimesters,Phase, Early Placental,Phases, Early Placental,Placental Phase, Early,Placental Phases, Early,Pregnancies, First Trimester,Pregnancy Trimesters, First,Trimesters, First
D005260 Female Females

Related Publications

Arsenio Spinillo, and Camilla Bellingeri, and Chiara Cavagnoli, and Irene De Maggio, and Greta Riceputi, and Beatrice Ruspini, and Stefania Cesari, and Fausta Beneventi
July 2018, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
Arsenio Spinillo, and Camilla Bellingeri, and Chiara Cavagnoli, and Irene De Maggio, and Greta Riceputi, and Beatrice Ruspini, and Stefania Cesari, and Fausta Beneventi
January 2022, Polish journal of pathology : official journal of the Polish Society of Pathologists,
Arsenio Spinillo, and Camilla Bellingeri, and Chiara Cavagnoli, and Irene De Maggio, and Greta Riceputi, and Beatrice Ruspini, and Stefania Cesari, and Fausta Beneventi
November 2021, Journal of gynecology obstetrics and human reproduction,
Arsenio Spinillo, and Camilla Bellingeri, and Chiara Cavagnoli, and Irene De Maggio, and Greta Riceputi, and Beatrice Ruspini, and Stefania Cesari, and Fausta Beneventi
September 2020, Zhonghua bing li xue za zhi = Chinese journal of pathology,
Arsenio Spinillo, and Camilla Bellingeri, and Chiara Cavagnoli, and Irene De Maggio, and Greta Riceputi, and Beatrice Ruspini, and Stefania Cesari, and Fausta Beneventi
June 2018, Placenta,
Arsenio Spinillo, and Camilla Bellingeri, and Chiara Cavagnoli, and Irene De Maggio, and Greta Riceputi, and Beatrice Ruspini, and Stefania Cesari, and Fausta Beneventi
January 2017, Placenta,
Arsenio Spinillo, and Camilla Bellingeri, and Chiara Cavagnoli, and Irene De Maggio, and Greta Riceputi, and Beatrice Ruspini, and Stefania Cesari, and Fausta Beneventi
January 2021, Placenta,
Arsenio Spinillo, and Camilla Bellingeri, and Chiara Cavagnoli, and Irene De Maggio, and Greta Riceputi, and Beatrice Ruspini, and Stefania Cesari, and Fausta Beneventi
March 2022, Reproductive medicine (Basel, Switzerland),
Arsenio Spinillo, and Camilla Bellingeri, and Chiara Cavagnoli, and Irene De Maggio, and Greta Riceputi, and Beatrice Ruspini, and Stefania Cesari, and Fausta Beneventi
February 2020, Placenta,
Arsenio Spinillo, and Camilla Bellingeri, and Chiara Cavagnoli, and Irene De Maggio, and Greta Riceputi, and Beatrice Ruspini, and Stefania Cesari, and Fausta Beneventi
December 1994, The Netherlands journal of medicine,
Copied contents to your clipboard!